CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • United States
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade Outset Medical, Inc. - OM CFD

    21.59
    3.1%
    0.13
    Low: 21.53
    High: 22.11
    Market Trading Hours* (UTC) Opens on Tuesday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.13
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.025457%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		0.003235%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 20%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Outset Medical Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 22.28
    Open* 21.98
    1-Year Change* -3%
    Day's Range* 21.53 - 22.11
    52 wk Range 11.41-30.55
    Average Volume (10 days) 396.32K
    Average Volume (3 months) 10.90M
    Market Cap 1.10B
    P/E Ratio -100.00K
    Shares Outstanding 49.23M
    Revenue 118.29M
    EPS -3.51
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Jul 31, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 2, 2023 22.28 0.48 2.20% 21.80 22.42 21.49
    Jun 1, 2023 21.80 1.07 5.16% 20.73 22.05 20.46
    May 31, 2023 20.83 -0.22 -1.05% 21.05 21.21 20.24
    May 30, 2023 21.22 -0.08 -0.38% 21.30 21.67 20.71
    May 26, 2023 21.38 1.76 8.97% 19.62 21.41 19.48
    May 25, 2023 20.20 0.23 1.15% 19.97 20.26 19.47
    May 24, 2023 20.30 0.77 3.94% 19.53 20.49 19.47
    May 23, 2023 20.13 -1.50 -6.93% 21.63 22.29 19.73
    May 22, 2023 22.06 1.31 6.31% 20.75 22.32 20.74
    May 19, 2023 21.18 0.19 0.91% 20.99 21.76 20.99
    May 18, 2023 21.03 1.50 7.68% 19.53 21.14 19.47
    May 17, 2023 20.08 0.10 0.50% 19.98 20.22 19.51
    May 16, 2023 20.14 0.37 1.87% 19.77 20.17 19.48
    May 15, 2023 20.11 0.09 0.45% 20.02 20.32 19.61
    May 12, 2023 19.98 0.01 0.05% 19.97 20.28 19.62
    May 11, 2023 20.15 -0.54 -2.61% 20.69 20.94 19.80
    May 10, 2023 20.87 0.59 2.91% 20.28 20.99 20.21
    May 9, 2023 20.26 0.50 2.53% 19.76 20.49 19.19
    May 8, 2023 19.93 -0.09 -0.45% 20.02 20.24 18.24
    May 5, 2023 20.79 -0.18 -0.86% 20.97 22.48 20.79

    Outset Medical, Inc. Events

    Time (UTC) Country Event
    Monday, July 31, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q2 2023 Outset Medical Inc Earnings Release
    Q2 2023 Outset Medical Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 6, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q3 2023 Outset Medical Inc Earnings Release
    Q3 2023 Outset Medical Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 115.375 102.602 49.935 15.078 2.007
    Revenue 115.375 102.602 49.935 15.078 2.007
    Cost of Revenue, Total 97.542 94.994 62.972 32.88 8.122
    Gross Profit 17.833 7.608 -13.037 -17.802 -6.115
    Total Operating Expense 277.761 233.121 168.969 85.385 48.57
    Selling/General/Admin. Expenses, Total 129.997 101.386 75.58 29.178 17.532
    Research & Development 48.855 36.741 28.85 23.327 22.916
    Operating Income -162.386 -130.519 -119.034 -70.307 -46.563
    Interest Income (Expense), Net Non-Operating -0.275 -1.217 -2.365 -1.772 -2.93
    Other, Net 0 0 -0.093 3.8 -0.262
    Net Income Before Taxes -162.661 -131.736 -121.492 -68.279 -49.755
    Net Income After Taxes -162.956 -131.935 -121.492 -68.299 -49.78
    Net Income Before Extra. Items -162.956 -131.935 -121.492 -68.299 -49.78
    Net Income -162.956 -131.935 -121.492 -68.299 -49.78
    Total Adjustments to Net Income 0 42.168 -17.163 -23.3
    Income Available to Common Excl. Extra. Items -162.956 -131.935 -79.324 -85.462 -73.08
    Income Available to Common Incl. Extra. Items -162.956 -131.935 -79.324 -85.462 -73.08
    Diluted Net Income -162.956 -131.935 -79.324 -85.462 -73.08
    Diluted Weighted Average Shares 48.161 45.589 42.722 45.2225 45.2225
    Diluted EPS Excluding Extraordinary Items -3.38357 -2.89401 -1.85675 -1.88981 -1.61601
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -3.36512 -2.89401 -1.82007 -1.88981 -1.61601
    Unusual Expense (Income) 1.367 0 1.567
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 33.467 32.007 27.761 25.057 30.55
    Revenue 33.467 32.007 27.761 25.057 30.55
    Cost of Revenue, Total 27.039 26.734 23.425 21.275 26.108
    Gross Profit 6.428 5.273 4.336 3.782 4.442
    Total Operating Expense 76.952 73.198 68.76 68.778 67.025
    Selling/General/Admin. Expenses, Total 36.12 33.653 32.276 33.982 30.086
    Research & Development 13.793 11.444 13.059 13.521 10.831
    Operating Income -43.485 -41.191 -40.999 -43.721 -36.475
    Interest Income (Expense), Net Non-Operating -0.294 -0.189 0.238 -0.022 -0.302
    Other, Net 0
    Net Income Before Taxes -43.779 -41.38 -40.761 -43.743 -36.777
    Net Income After Taxes -43.971 -41.444 -40.781 -43.839 -36.892
    Net Income Before Extra. Items -43.971 -41.444 -40.781 -43.839 -36.892
    Net Income -43.971 -41.444 -40.781 -43.839 -36.892
    Total Adjustments to Net Income
    Income Available to Common Excl. Extra. Items -43.971 -41.444 -40.781 -43.839 -36.892
    Income Available to Common Incl. Extra. Items -43.971 -41.444 -40.781 -43.839 -36.892
    Diluted Net Income -43.971 -41.444 -40.781 -43.839 -36.892
    Diluted Weighted Average Shares 48.783 49.139 48.129 47.882 47.487
    Diluted EPS Excluding Extraordinary Items -0.90136 -0.8434 -0.84733 -0.91556 -0.77689
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.90136 -0.82532 -0.84733 -0.91556 -0.77689
    Unusual Expense (Income) 1.367
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 373.645 409.802 345.911 79.646 147.646
    Cash and Short Term Investments 287.502 339.488 314.87 69.378 142.782
    Cash & Equivalents 73.222 182.348 294.972 36.226 33.264
    Short Term Investments 214.28 157.14 19.898 33.152 109.518
    Total Receivables, Net 28.07 25.6 6.468 3.914 1.088
    Accounts Receivable - Trade, Net 28.07 25.6 6.468 3.914 1.088
    Total Inventory 51.476 39.185 18.384 4.596 3.022
    Prepaid Expenses 6.597 5.529 6.189 1.058 0.754
    Total Assets 400.115 463.464 403.829 88.366 151.13
    Property/Plant/Equipment, Total - Net 21.993 20.195 23.251 7.895 2.926
    Property/Plant/Equipment, Total - Gross 32.8 27.849 28.239 10.565 5.149
    Accumulated Depreciation, Total -10.807 -7.654 -4.988 -2.67 -2.223
    Other Long Term Assets, Total 4.477 33.467 34.667 0.825 0.558
    Total Current Liabilities 51.949 51.695 36.692 24.91 10.213
    Accounts Payable 0.603 1.763 4.948 4.96 3.373
    Accrued Expenses 35.575 39.575 26.578 10.43 5.349
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 7.509 0.01
    Other Current Liabilities, Total 15.771 10.357 5.166 2.011 1.481
    Total Liabilities 154.125 89.383 75.22 51.107 46.796
    Total Long Term Debt 96.336 29.762 29.674 21.561 28.355
    Long Term Debt 96.336 29.762 29.674 21.561 28.346
    Capital Lease Obligations 0 0.009
    Other Liabilities, Total 5.84 7.926 8.854 4.636 8.228
    Total Equity 245.99 374.081 328.609 37.259 104.334
    Redeemable Preferred Stock 0 0 0 409.446 392.284
    Common Stock 0.048 0.047 0.043 0.007 0.006
    Additional Paid-In Capital 1035.46 1000.21 822.624 0.356 0
    Retained Earnings (Accumulated Deficit) -788.95 -625.994 -494.059 -372.572 -287.896
    Unrealized Gain (Loss) -0.564 -0.184 0.001 0.022 -0.06
    Total Liabilities & Shareholders’ Equity 400.115 463.464 403.829 88.366 151.13
    Total Common Shares Outstanding 48.465 47.241 42.722 45.2225 45.2225
    Other Current Assets, Total 0.7
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 337.275 373.645 310.003 345.777 377.426
    Cash and Short Term Investments 249.213 287.502 227.517 262.062 302.267
    Cash & Equivalents 36.386 73.222 63.877 75.497 114.346
    Short Term Investments 212.827 214.28 163.64 186.565 187.921
    Total Receivables, Net 34.314 28.07 22.512 24.627 26.899
    Accounts Receivable - Trade, Net 34.314 28.07 22.512 24.627 26.899
    Total Inventory 47.733 51.476 55.26 53.689 42.873
    Prepaid Expenses 6.015 6.597 4.714 5.399 5.387
    Total Assets 362.665 400.115 365.722 401.236 431.742
    Property/Plant/Equipment, Total - Net 21.012 21.993 22.022 21.932 20.844
    Other Long Term Assets, Total 4.378 4.477 33.697 33.527 33.472
    Total Current Liabilities 44.268 51.949 49.644 55.24 48.89
    Accounts Payable 1.988 0.603 1.444 2.753 5.149
    Accrued Expenses 27.957 35.575 34.041 36.973 30.789
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 14.323 15.771 14.159 14.514 12.952
    Total Liabilities 146.379 154.125 86.619 91.472 86.289
    Total Long Term Debt 96.48 96.336 29.828 28.806 29.784
    Long Term Debt 96.48 96.336 29.828 28.806 29.784
    Other Liabilities, Total 5.631 5.84 7.147 7.426 7.615
    Total Equity 216.286 245.99 279.103 309.764 345.453
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.049 0.048 0.048 0.048 0.048
    Additional Paid-In Capital 1049.27 1035.46 1027.49 1017.4 1008.94
    Retained Earnings (Accumulated Deficit) -832.921 -788.95 -747.506 -706.725 -662.886
    Unrealized Gain (Loss) -0.113 -0.564 -0.934 -0.955 -0.649
    Total Liabilities & Shareholders’ Equity 362.665 400.115 365.722 401.236 431.742
    Total Common Shares Outstanding 49.216 48.465 48.295 47.997 47.712
    Current Port. of LT Debt/Capital Leases 1
    Property/Plant/Equipment, Total - Gross 32.8
    Accumulated Depreciation, Total -10.807
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -162.956 -131.935 -121.492 -68.299 -49.78
    Cash From Operating Activities -145.729 -130.264 -99.015 -70.292 -46.442
    Cash From Operating Activities 5.169 5.162 3.159 1.484 1.069
    Non-Cash Items 33.2 22.112 25.167 -1.878 2.486
    Cash Taxes Paid 0.385 0.083 0.019 0.035 0.009
    Changes in Working Capital -21.142 -25.603 -5.849 -1.599 -0.217
    Cash From Investing Activities -66.295 -142.507 3.947 74.297 -68.776
    Capital Expenditures -8.325 -3.108 -9.108 -3.293 -1.766
    Other Investing Cash Flow Items, Total -57.97 -139.399 13.055 77.59 -67.01
    Cash From Financing Activities 72.898 160.147 385.682 0.249 134.872
    Financing Cash Flow Items -0.181 0
    Issuance (Retirement) of Stock, Net 8.042 160.147 387.046 0.439 134.881
    Issuance (Retirement) of Debt, Net 64.856 0 -1.364 -0.009 -0.009
    Net Change in Cash -139.126 -112.624 290.614 4.254 19.654
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -43.971 -162.956 -121.512 -80.731 -36.892
    Cash From Operating Activities -44.756 -145.729 -111.222 -76.91 -38.335
    Cash From Operating Activities 1.384 5.169 3.9 2.586 1.262
    Non-Cash Items 8.598 33.2 23.826 15.118 6.581
    Cash Taxes Paid 0.201 0.385 0.334 0.283 0.205
    Changes in Working Capital -10.767 -21.142 -17.436 -13.883 -9.286
    Cash From Investing Activities 2.643 -66.295 -14.547 -34.706 -33.39
    Capital Expenditures -0.81 -8.325 -6.216 -3.475 -1.478
    Other Investing Cash Flow Items, Total 3.453 -57.97 -8.331 -31.231 -31.912
    Cash From Financing Activities 5.277 72.898 7.298 4.765 3.723
    Issuance (Retirement) of Stock, Net 5.277 8.042 7.433 4.765 3.723
    Issuance (Retirement) of Debt, Net 64.856
    Net Change in Cash -36.836 -139.126 -118.471 -106.851 -68.002
    Financing Cash Flow Items -0.135
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fidelity Management & Research Company LLC Investment Advisor 14.77 7270972 49376 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.4572 4655616 82430 2023-03-31 LOW
    T. Rowe Price Investment Management, Inc. Investment Advisor 6.6916 3294148 -225722 2023-03-31 MED
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2155 3059782 -77314 2023-03-31 LOW
    Bellevue Asset Management AG Investment Advisor 5.9047 2906759 63080 2023-03-31 LOW
    JP Morgan Asset Management Investment Advisor 5.5577 2735954 169738 2023-03-31 LOW
    JPMorgan Asset Management U.K. Limited Investment Advisor/Hedge Fund 3.8619 1901126 91339 2023-03-31 LOW
    Champlain Investment Partners, LLC Investment Advisor 3.7109 1826825 -33580 2023-03-31 LOW
    Braidwell LP Hedge Fund 3.5637 1754350 49798 2023-03-31 HIGH
    Mubadala Investment Company PJSC Sovereign Wealth Fund 2.9346 1444665 -1445678 2021-12-07 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.6458 1302457 129782 2023-03-31 LOW
    Eagle Health Investments LP Hedge Fund 2.4384 1200385 -20224 2023-03-31 MED
    Perceptive Advisors LLC Private Equity 2.213 1089427 0 2023-03-31 MED
    C WorldWide Asset Management Fondsmaeglerselskab A/S Investment Advisor 2.0314 1000000 0 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8701 920601 35123 2023-03-31 LOW
    Pura Vida Investments, LLC Hedge Fund 1.8671 919136 464746 2023-03-31 HIGH
    RTW Investments L.P. Investment Advisor/Hedge Fund 1.6427 808658 -100994 2023-03-31 LOW
    Columbia Wanger Asset Management, LLC Investment Advisor 1.4124 695303 157420 2023-03-31 MED
    Jennison Associates LLC Investment Advisor/Hedge Fund 1.2327 606819 -3405 2023-03-31 LOW
    Mellon Investments Corporation Investment Advisor/Hedge Fund 1.1932 587411 -16224 2023-03-31 LOW

    Start a global, multi-asset portfolio with an award-winning platform

    Desktop

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    Outset Medical, Inc. Company profile

    About Outset Medical Inc

    Outset Medical, Inc. is a medical technology company that offers Tablo. Tablo is a mobile integrated hemodialysis solution for acute and home hemodialysis therapy. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to access a single platform from the hospital to the home. The Tablo cartridge is a single use consumable intended to facilitate extracorporeal blood purification for patients and consists of a pre-configured blood, saline, and infusion tubing. Tablo’s touch screen panel enables the user to navigate through the treatment with animations and non-technical language, tailored to both professional and non-professional users. Tablo’s cloud connectivity software enables an ecosystem of machine diagnostics and analytics, treatment instruction, monitoring and reporting, improved documentation and remote machine management. In addition, Tablo also delivers robust clinical care.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Outset Medical Inc revenues increased from $49.9M to $102.6M. Net loss applicable to common stockholders increased 66% to $131.9M. Revenues reflect Consoles segment increase of 98% to $65.1M, Consumables segment increase from $6.7M to $19.2M. Higher net loss reflects Sales and marketing - Balancing value increase of 46% to $59.2M (expense).

    Industry: Advanced Medical Equipment & Technology (NEC)

    3052 Orchard Drive
    SAN JOSE
    CALIFORNIA 95134
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Turkish lira on top of USA national currency, top view of mixed American dollars banknotes. TRY and USA paper money. Lira and US dollars exchange rate

    USD/TRY forecast: Turkish lira under pressure from high inflation and low rates

    We look at some of the latest USD/TRY predictions as the Turkish lira hits record lows.

    17:07, 1 June 2023
    Nvidia HQ in Santa Clara, California

    Nvidia’s 5-year stock forecast: Will the chipmaker remain at record highs?

    Nvidia has been the winner of the AI race, being the first chip-maker to hit a $1tn market cap. Will the growth continue?

    07:46, 31 May 2023
    Alphabet Inc and Google logos on a smartphone screen

    Google stock forecast 2023-2025

    What is the outlook for the tech giant, following a tumultuous 2022?

    18:02, 30 May 2023
    Benjamin Franklin’s face on a $100 bill

    USD forecast: DXY slides in risk-off market sentiment

    The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.

    16:10, 24 May 2023
    Oil wells pictured in an oil field, silhouetted against clouds

    Oil price forecast: Will WTI and Brent regain momentum in 2023?

    Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.

    11:38, 22 May 2023
    businessman using a mobile phone to check stock market data

    Weekly Roundup: Tech stocks lead the way

    US stocks push higher as risk appetite surges despite the uncertainty

    13:39, 19 May 2023
    Japanese yen currency

    USD/JPY continues to build higher towards 138

    USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher

    11:50, 17 May 2023

    People also watch

    XRP/USD

    0.51 Price
    -7.350% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.00400

    Oil - Crude

    71.94 Price
    -0.010% 1D Chg, %
    Long position overnight fee -0.0149%
    Short position overnight fee -0.0070%
    Overnight fee time 21:00 (UTC)
    Spread 0.03

    Gold

    1,961.31 Price
    +0.690% 1D Chg, %
    Long position overnight fee -0.0184%
    Short position overnight fee 0.0102%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    US100

    14,538.70 Price
    -0.080% 1D Chg, %
    Long position overnight fee -0.0255%
    Short position overnight fee 0.0032%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 535.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading